Literature DB >> 15704692

Female breast cancers are getting smaller, but socio-demographic differences remain.

Colin Luke1, Anh-Minh Nguyen, Kevin Priest, David Roder.   

Abstract

OBJECTIVE: To investigate trends towards early detection of infiltrating ductal carcinomas, possible effects on patients' prognosis, and characteristics of women still at high risk of late detection.
METHODS: South Australian Cancer Registry data were analysed to compare breast tumour diameters for the 1980-86 and 1997-2002 diagnostic periods by age. Relative survivals for 1980-86 were compared with corresponding survival estimates for 1997-2000, obtained by weighting diameter-specific survivals for 1980-86 to equate with the diameter distribution for 1997-2002. Multivariable logistic regression was used to determine socio-demographic predictors of large diameters (> or =30 mm) in 1997-2002.
RESULTS: The proportion of tumours with diameters smaller than 15 mm increased from 13.0% in 1980-86 to 36.7% in 1997-2002, whereas the proportion with large diameters reduced from 43.0% to 18.6%. Estimated changes in 20-year survivals equated with a 33% reduction in breast-cancer mortality among patients aged 50-69 years at diagnosis. Data for 1997-2002 indicate that early diagnosis is not evenly distributed, with large diameters more common in age ranges outside the 50-69 year target for mammography screening; low socio-economic areas; non-Caucasians; patients born in northern/eastern Europe and potentially Asia/Middle East; and in some country locations. CONCLUSIONS AND IMPLICATIONS: Increased emphasis on early detection should be directed at sectors of the population where delays in diagnosis and poorer prognosis are evident. Projected reductions in breast-cancer mortality among patients are indicative of effects of earlier detection on patients' prognosis, but require confirmation with follow-up data. More particularly, parallel studies of effects on population-based mortality are warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15704692     DOI: 10.1111/j.1467-842x.2004.tb00435.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  7 in total

1.  Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.

Authors:  Mary C Schroeder; Charles F Lynch; Taher Abu-Hejleh; Elizabeth A Chrischilles; Alexandra Thomas
Journal:  Clin Breast Cancer       Date:  2014-08-18       Impact factor: 3.225

2.  An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma.

Authors:  Megan E Downing; Gillian S Dite; Mandy L Ballinger
Journal:  Clin Sarcoma Res       Date:  2012-01-09

Review 3.  Understanding the effects of socioeconomic status along the breast cancer continuum in Australian women: a systematic review of evidence.

Authors:  Greg Lyle; Gilly A Hendrie; Delia Hendrie
Journal:  Int J Equity Health       Date:  2017-10-16

4.  Variations in outcomes by residential location for women with breast cancer: a systematic review.

Authors:  Paramita Dasgupta; Peter D Baade; Danny R Youlden; Gail Garvey; Joanne F Aitken; Isabella Wallington; Jennifer Chynoweth; Helen Zorbas; Philippa H Youl
Journal:  BMJ Open       Date:  2018-04-29       Impact factor: 2.692

5.  Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database.

Authors:  Junzhao Wu; Minhao Lv; Peng Yuan; Youzhao Ma; Peiqi Tian; Lianfang Li; Chengzheng Wang; Zhenduo Lu; Min Yan; Xiuchun Chen; Zhenzhen Liu
Journal:  Gland Surg       Date:  2022-08

6.  Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements.

Authors:  Julia F Stanbury; Peter D Baade; Yan Yu; Xue Qin Yu
Journal:  BMC Cancer       Date:  2016-02-01       Impact factor: 4.430

7.  Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.

Authors:  Carmine De Angelis; Massimo Di Maio; Anna Crispo; Mario Giuliano; Francesco Schettini; Marta Bonotto; Lorenzo Gerratana; Donatella Iacono; Marika Cinausero; Ferdinando Riccardi; Giuseppe Ciancia; Michelino De Laurentiis; Fabio Puglisi; Sabino De Placido; Grazia Arpino
Journal:  Oncotarget       Date:  2017-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.